Nature Reviews Gastroenterology & Hepatology, Published online: 16 November 2026; doi:10.1038/s41575-026-01275-9 This Review discusses the complex role of epigenetics in inflammatory bowel disease and provides a comprehensive overview of current and emerging technologies that could enhance the prognostic value of epigenetic biomarkers.
Catia S. R. Antunes, Alexandra Noble, Anouschka S. Ramsteijn, Jack Satsangi. Epigenetics in inflammatory bowel disease: from mechanistic insights to personalized therapeutic strategies. // Nature Reviews Gastroenterology & Hepatology. – 2026. – DOI: 10.1038/s41575-026-01275-9. – URL: https://www.nature.com/articles/s41575-026-01275-9
Catia S. R. Antunes, Alexandra Noble, Anouschka S. Ramsteijn, & Jack Satsangi (2026). Epigenetics in inflammatory bowel disease: from mechanistic insights to personalized therapeutic strategies. Nature Reviews Gastroenterology & Hepatology. https://doi.org/10.1038/s41575-026-01275-9
Catia S. R. Antunes, et al. “Epigenetics in inflammatory bowel disease: from mechanistic insights to personalized therapeutic strategies.” Nature Reviews Gastroenterology & Hepatology, 2026. doi:10.1038/s41575-026-01275-9.
@article{Antunes2026,
title = {Epigenetics in inflammatory bowel disease: from mechanistic insights to personalized therapeutic strategies},
author = {Antunes, Catia S. R. and Noble, Alexandra and Ramsteijn, Anouschka S. and Satsangi, Jack},
journal = {Nature Reviews Gastroenterology \& Hepatology},
year = {2026},
doi = {10.1038/s41575-026-01275-9},
url = {https://www.nature.com/articles/s41575-026-01275-9}
}